Motor Neurone Disease Trial, Recruiting NCT04394871 Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT04394871
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be age 5 or older
  • You may qualify under one of several groups: (1) you have a genetic diagnosis of ALS4 (a specific gene mutation called SETX); (2) you have a genetic diagnosis of a related condition affecting how the body processes genetic material (such as RNaseH1, RNaseH2, or recessive SETX mutations); (3) you are a healthy family member (first, second, or third degree relative) of someone with one of these genetic mutations; (4) you are an unrelated healthy person with no such family history; or (5) you have a genetic diagnosis of a "gain of function" mutation (for example, certain mutations in SETX or KCC3)
  • You must be able to communicate well with the research team and be willing and able to follow the study requirements
  • Adults must be able to give their own consent to participate; children must be able to give their agreement (assent) to take part

Who may not be able to join:

  • You are pregnant
  • You have a known fear of enclosed spaces (claustrophobia), a pacemaker, metal in your body, or any other condition that would make having an MRI scan unsafe (applies to some groups — confirm with trial site)
  • You have a diagnosed neuromuscular disease or show muscle weakness on a physical exam (applies to healthy control groups)
  • For adults who would be asked to have a spinal fluid sample (lumbar puncture) taken: you have abnormal blood clotting test results, a low platelet count (below 70,000), a history of a bleeding disorder, or you are taking blood-thinning medications — these individuals would not be able to take part in that specific procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christopher Grunseich, M.D., National Institute of Neurological Disorders and Stroke (NINDS)

Phone: (301) 451-8146

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 December 2020
Est. completion
25 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Disease progression as measured by thigh muscle volume and other study measures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov